Pancreatic Cancer Research

ResearcherCentre National de la Recherche ScientifiqueNo recent work listed

Véronique Secq

Verified by OpenAlex author ID (good confidence, 0.85), identity_conf@1As of 7 November 2026

Matched on OpenAlex author ID A5011899830. Sources: OpenAlex.

Their work

Papers
12
Trials
0
Grants
0
Labs led
0
Collaborators
48
Papers, trials and grants by year

2012: 1 paper · 2013: none · 2014: none · 2015: 3 papers · 2016: 2 papers · 2017: 4 papers · 2018: 2 papers

Papers 12

  1. Distinct epigenetic landscapes underlie the pathobiology of pancreatic cancer subtypes. Co-author DOI 10.1038/s41467-018-04383-6↗
  2. LIF Drives Neural Remodeling in Pancreatic Cancer and Offers a New Candidate Biomarker. Co-author DOI 10.1158/0008-5472.can-15-2790↗
  3. Pancreatic Adenocarcinoma Therapeutic Targets Revealed by Tumor-Stroma Cross-Talk Analyses in Patient-Derived Xenografts. Co-author DOI 10.1016/j.celrep.2017.11.003↗
  4. Collagen-derived proline promotes pancreatic ductal adenocarcinoma cell survival under nutrient limited conditions. Co-author DOI 10.1038/ncomms16031↗
  5. BTN3A is a prognosis marker and a promising target for Vγ9Vδ2 T cells based-immunotherapy in pancreatic ductal adenocarcinoma (PDAC). Co-author DOI 10.1080/2162402x.2017.1372080↗
  6. Gene expression profiling of patient-derived pancreatic cancer xenografts predicts sensitivity to the BET bromodomain inhibitor JQ1: implications for individua… Co-author DOI 10.15252/emmm.201606975↗
  7. Cancer-associated fibroblast-derived annexin A6+ extracellular vesicles support pancreatic cancer aggressiveness. Co-author DOI 10.1172/jci87734↗
  8. A pancreatic ductal adenocarcinoma subpopulation is sensitive to FK866, an inhibitor of NAMPT. Co-author DOI 10.18632/oncotarget.10776↗
  9. Transcriptomic analysis predicts survival and sensitivity to anticancer drugs of patients with a pancreatic adenocarcinoma. Co-author DOI 10.1016/j.ajpath.2014.11.029↗
  10. Stromal SLIT2 impacts on pancreatic cancer-associated neural remodeling. Co-author DOI 10.1038/cddis.2014.557↗
  11. A subgroup of pancreatic adenocarcinoma is sensitive to the 5-aza-dC DNA methyltransferase inhibitor. Co-author DOI 10.18632/oncotarget.2685↗
  12. Homotypic cell cannibalism, a cell-death process regulated by the nuclear protein 1, opposes to metastasis in pancreatic cancer. Co-author DOI 10.1002/emmm.201201255↗

Closest collaborators

The 25 strongest of 48 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Juan Iovanna · 12 shared papers, 2012–2018 · strength 0.54
  2. Nelson Dusetti · 9 shared papers, 2015–2018 · strength 0.40
  3. Mehdi Ouaïssi · 8 shared papers, 2015–2018 · strength 0.35
  4. Céline Loncle · 8 shared papers, 2012–2017 · strength 0.33
  5. Olivıer Turrini · 7 shared papers, 2012–2018 · strength 0.29
  6. Sophie Vasseur · 6 shared papers, 2015–2018 · strength 0.28
  7. Odile Gayet · 6 shared papers, 2015–2018 · strength 0.26
  8. Marc F. Giovannini · 6 shared papers, 2015–2018 · strength 0.26
  9. Marine Gilabert · 6 shared papers, 2015–2018 · strength 0.26
  10. Pauline Duconseil · 5 shared papers, 2015–2018 · strength 0.21
  11. Julie Roques · 4 shared papers, 2016–2018 · strength 0.21
  12. Fabienne Guillaumond · 4 shared papers, 2015–2018 · strength 0.20
  13. Richard Tomasini · 4 shared papers, 2015–2018 · strength 0.20
  14. Benjamin Bian · 4 shared papers, 2016–2018 · strength 0.19
  15. Jean‐Robert Delpéro · 4 shared papers, 2016–2018 · strength 0.19
  16. Raul A. Urrutia · 4 shared papers, 2012–2018 · strength 0.17
  17. Gwen Alyce Lomberk · 4 shared papers, 2012–2018 · strength 0.17
  18. Jean‐Luc Raoul · 4 shared papers, 2015–2017 · strength 0.17
  19. Christian Bressy · 3 shared papers, 2015–2018 · strength 0.15
  20. Julie Leca · 3 shared papers, 2015–2018 · strength 0.15
  21. Jérémy Nigri · 3 shared papers, 2015–2018 · strength 0.15
  22. Rémy Nicolle · 3 shared papers, 2017–2018 · strength 0.14
  23. Anthony Gonçalvès · 3 shared papers, 2015–2017 · strength 0.12
  24. Daniel Pietrasz · 2 shared papers, 2016–2018 · strength 0.11
  25. Jean‐Baptiste Bachet · 2 shared papers, 2016–2018 · strength 0.11

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.